Owners, management and financials
CVR: 37988936
DKK -43,536
Gross profit
Net result: DKK -87,006
Bo Jesper Hansen (50-66,65%), Pär Ingemar Johansson (50-66,65%)
1 more
CVR · view owners
Rikke Stine Friis Fléron
CVR · view management
Active
Founded 31 August 2016
CVR · view overview
0 employees
Annual report 2025 · average
Director registered: Rikke Stine Friis Fléron
CVR · 01/04/2026
View the full event history
Endothel Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Rikke Stine Friis Fléron. The company is owned by Bo Jesper Hansen, Pär Ingemar Johansson and Trial-Lab Holding AB. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -43,536 and a net result of DKK -87,006 compared with DKK -81,618 the year before. Equity in the 2025 report amounted to DKK -462,946.
Selskabets formål er at udvikle lægemidler samt dermed beslægtet virksomhed
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -44K | -87K | 563K | -463K | 0 | |
| 202401/01/2024 – 31/12/2024 | -42K | -82K | 575K | -376K | 0 | |
| 202301/01/2023 – 31/12/2023 | -57K | -91K | 559K | -294K | 0 | |
| 202201/01/2022 – 31/12/2022 | -48K | -76K | 555K | -203K | 0 | |
| 202101/01/2021 – 31/12/2021 | -25K | -47K | 543K | -127K | 0 | |
| 202001/01/2020 – 31/12/2020 | -13K | -29K | 368K | -80K | 0 | |
| 201901/01/2019 – 31/12/2019 | -23K | -36K | 331K | -52K | - | |
| 201801/01/2018 – 31/12/2018 | -53K | -59K | 302K | -40K | 0 |
Compared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Endothel Pharma ApS is 37988936.
Endothel Pharma ApS is owned by Bo Jesper Hansen, Pär Ingemar Johansson and Trial-Lab Holding AB.
The management of Endothel Pharma ApS consists of Rikke Stine Friis Fléron.
In 2025, Endothel Pharma ApS reported a gross profit of DKK -43,536.
Endothel Pharma ApS had an average of 0 employees in the 2025 financial year according to the annual report.
Endothel Pharma ApS was founded on 31 August 2016.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new email: [email protected] (April 2, 2026).
As of April 1, 2026, Rikke Stine Friis Fléron is registered as director of Endothel Pharma ApS.
As of March 31, 2026, Sisse Rye Ostrowski has stepped down as director of Endothel Pharma ApS.
Contact info changed: new email: [email protected] (March 27, 2026).
As of February 17, 2026, Bo Jesper Hansen is registered as an owner of Endothel Pharma ApS with an ownership share of 50%.
As of February 17, 2026, is registered as an owner of Endothel Pharma ApS with an ownership share of 50%.
As of February 17, 2026, is registered as an owner of Endothel Pharma ApS with an ownership share of 50%.
Endothel Pharma ApS has published its annual report for 2025. Gross profit came to DKK -43,536, and the net result was DKK -87,006.
Endothel Pharma ApS has published its annual report for 2024. Gross profit came to DKK -42,292, and the net result was DKK -81,618.
Endothel Pharma ApS has published its annual report for 2023. Gross profit came to DKK -57,141, and the net result was DKK -91,000.
Endothel Pharma ApS has published its annual report for 2022. Gross profit came to DKK -47,868, and the net result was DKK -76,253.
Endothel Pharma ApS has published its annual report for 2021. Gross profit came to DKK -25,128, and the net result was DKK -46,607.
Endothel Pharma ApS has published its annual report for 2020. Gross profit came to DKK -12,618, and the net result was DKK -28,925.
Endothel Pharma ApS has published its annual report for 2019. Gross profit came to DKK -23,142, and the net result was DKK -36,111.
Endothel Pharma ApS has published its annual report for 2018. Gross profit came to DKK -52,984, and the net result was DKK -59,310.
Endothel Pharma ApS has published its interim report for the period August 31, 2016 to December 31, 2017.
As of April 10, 2017, Leif Helth Jensen has left the board of directors of Endothel Pharma ApS.
As of April 10, 2017, Sisse Rye Ostrowski has left the board of directors of Endothel Pharma ApS.
As of April 10, 2017, Pär Ingemar Johansson has left the board of directors of Endothel Pharma ApS.
As of April 10, 2017, Sisse Rye Ostrowski is registered as director of Endothel Pharma ApS.
As of April 10, 2017, Leif Helth Jensen has stepped down as director of Endothel Pharma ApS.
As of August 31, 2016, Leif Helth Jensen has joined the board of directors of Endothel Pharma ApS.
As of August 31, 2016, Sisse Rye Ostrowski has joined the board of directors of Endothel Pharma ApS.
As of August 31, 2016, Pär Ingemar Johansson has joined the board of directors of Endothel Pharma ApS.
As of August 31, 2016, Leif Helth Jensen is registered as director of Endothel Pharma ApS.
Endothel Pharma ApS was founded on August 31, 2016.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 45984842
CVR 33871902
CVR 37033308
CVR 34498288
CVR 37007617
